Clinical Trials Directory

Trials / Completed

CompletedNCT00660413

Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents

Comparison of Acceleromyography and Mechanomyography for Establishing Potency of Neuromuscular Blocking Agents, A Randomized Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to compare two methods for neuromuscular monitoring, acceleromyography and mechanomyography for establishing the dose-response relationship and the potency of a neuromuscular blocking agent using rocuronium as an example. We hypothesized that there would be no significant difference between potencies estimated using acceleromyography and mechanomyography.

Conditions

Interventions

TypeNameDescription
DEVICETOF-Watch SX (Acceleromyography)Randomization of AMG to dominant or non-dominant arm. MMG at contralateral arm.

Timeline

Start date
2007-12-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2008-04-17
Last updated
2008-04-17

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00660413. Inclusion in this directory is not an endorsement.

Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agen (NCT00660413) · Clinical Trials Directory